Mettler-Toledo International (MTD) 7th Annual Evercore ISI HealthCONx Conference summary

Third quarter performance and business highlights

• Q3 results were in line with expectations, with 5% growth in the lab business and strong process analytics and analytical instrumentation performance.

• Europe showed resilience despite economic pressures, and China returned to modest growth after a reset period.

• Service business grew 9%, with above-average margins and strong execution in margin expansion initiatives.

• Gross margin increased by 60 basis points in the quarter, and cash flow per share rose 7% year-to-date.

• Industrial segment was softer, mainly due to China, but benefited from automation and digitalization trends.

Regional and segment outlook

• Industrial business in China remains soft, with global exposure at 25% but over 40% in China.

• Cautious guidance for industrial due to project delays and economic uncertainty, but long-term optimism remains due to reshoring and automation trends.

• Q4 guidance assumes a 6% sequential revenue increase, below historical trends, mainly due to caution in China and mixed U.S. performance.

• China lab business is about half of local revenue, with core industrial over 40%; most sales are to private Chinese companies.

• Fiscal 2025 guidance for China assumes low single-digit growth, with gradual improvement expected and limited stimulus impact.

Market and macroeconomic factors

• Exposure to NIH is insignificant, and value chain focus is on late-stage development and production environments.

• Tariff exposure from China is under $100 million, with mitigation strategies in place; European imports are also monitored for potential tariffs.

• No significant impact from recent changes at FDA, CMS, or HHS reported by customers.

• Fiscal stimulus in China could be a future growth driver, but current targeted programs have limited impact.

• Emerging markets outside China, such as India and Southeast Asia, each represent low single-digit percentages of business but are seen as growth opportunities.